FindTrial
Sign In

The study for the difference of circulating tumor cells in arterial and venous blood in lung cancer patients

The study for the difference of circulating tumor cells and ctDNA in arterial and venous blood in lung cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018907
Enrollment
Unknown
Registered
2018-10-16
Start date
2018-10-21
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Case series:none

Sponsors

The 113th Hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Lung cancer patients aged 18 to 80 who were diagnosed pathologically.

Exclusion criteria

Exclusion criteria: The patients in crictical conditions with unstable vital signs.

Design outcomes

Primary

MeasureTime frame
CTC count;—

Countries

China

Contacts

Public ContactWei-Liang Li

The 113th Hospital of PLA

ipec2012@126.com+86 13906688746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026